Efficacy of carotid endarterectomy translates to being efficacious with appropriate surgical skill

Archives of Neurology

Volumn 59, Issue 12, 2002, Pages 1866-1868

  Barnett, H J M ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; FIBRINOLYTIC AGENT;

ANTICOAGULANT THERAPY; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; DATA BASE; DRUG EFFICACY; EDITORIAL; FIBRINOLYTIC THERAPY; HEART ATRIUM FIBRILLATION; HIGH RISK POPULATION; HOSPITAL DISCHARGE; HUMAN; MEDICAL AUDIT; MEDICAL CARE; MEDICAL DECISION MAKING; MEDICAL RECORD; NEUROLOGIC EXAMINATION; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; PUBLICATION; RISK ASSESSMENT; RISK FACTOR; SKILL; STROKE; SURGEON; SURGICAL MORTALITY; SURGICAL RISK; SURGICAL TECHNIQUE; SURVIVAL; TREATMENT OUTCOME;

CEREBROVASCULAR ACCIDENT; ENDARTERECTOMY, CAROTID; HUMANS;

EID: 0036895146     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.59.12.1866     Document Type: Editorial

References (12)

1. CAPRIE Steering Committee: A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339
2. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): A randomized trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet. 1997;349:1569-1581.
3. The EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. N Engl J Med. 1985;313:1911-1200.
4. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Steering Committee. North American Symptomatic Carotid Endarterectomy Trial. Methods, patient characteristics, and progress. Stroke. 1991;22:711-720.
5. Barnett HJM, Meldrum HE, Eliasziw M. The appropriate use of carotid endarterectomy. CMAJ. 2002;166:1169-1179.
6. Feasby TE, Quan H, Ghali WA. Hospital and surgeon determinants of carotid endarterectomy outcomes. Arch Neurol. 2002;59:1877-1881.
7. Barnett HJM, Taylor DW, Eliasziw M, et al, for the North American Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of carotid endarterectomy in symptomatic patients with moderate and severe stenosis. N Engl J Med. 1998;339:1415-1425.
8. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273:1421-1428.
9. Hobson RW II, Weiss DG, Fields WS, Goldstone J, Moore WS, Towne JB, et al and the Veterans Affairs Cooperataive Study Group. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med. 1993;328:221-227.
10. Taylor DW, Barnett HJM, Haynes RB, Ferguson GG, Sackett DL, Thorpe KE, et al, for the ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Low-dose and highdose acetylsalicylic acid for patients undergoing carotid endarterectomy: A randomized controlled trial. Lancet. 1999;353:2179-84.
11. Kresowick TF, Bratzler D, Karp HR, et al. Multistate utilization, processes, and outcomes of carotid endarterectomy. J Vasc Surg. 2001;33:227-235.
12. Rothwell PM, Slattery W, Warlow CP. A systematic review of the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. Stroke. 1996;27:260-265